pI: 8.4868 |
Length (AA): 110 |
MW (Da): 12418 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
6 | 98 | 6en4 (D) | 6 | 98 | 94.00 | 0 | 1 | 1.95295 | -0.75 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128251)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G07170 | splicing factor 3b-like protein |
Arabidopsis thaliana | AT2G30000 | PHD finger-like domain-containing protein 5A |
Brugia malayi | Bm1_25020 | PHD finger-like domain protein 5A |
Candida albicans | CaO19.9772 | similar to S. cerevisiae YPR094W |
Candida albicans | CaO19.2230 | similar to S. cerevisiae YPR094W |
Caenorhabditis elegans | CELE_Y54F10BM.14 | Protein PHF-5 |
Cryptosporidium parvum | cgd6_2400 | hypothetical protein |
Dictyostelium discoideum | DDB_G0284403 | PHD finger-like domain-containing protein 5A |
Drosophila melanogaster | Dmel_CG9548 | CG9548 gene product from transcript CG9548-RA |
Echinococcus granulosus | EgrG_000615900 | PHD finger 5A |
Entamoeba histolytica | EHI_081770 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000615900 | PHD finger 5A |
Giardia lamblia | GL50803_32531 | Hypothetical protein |
Homo sapiens | ENSG00000100410 | PHD finger protein 5A |
Leishmania braziliensis | LbrM.35.3140 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_363070.1 | PHF5-like protein, putative |
Leishmania infantum | LinJ.36.3070 | hypothetical protein, conserved |
Leishmania major | LmjF.36.2920 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.2920 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_06442 | hypothetical protein |
Mus musculus | 68479 | PHD finger protein 5A |
Neospora caninum | NCLIV_064230 | pre-mRNA-splicing factor, putative |
Oryza sativa | 4337303 | Os04g0663300 |
Oryza sativa | 4338563 | Os05g0367000 |
Plasmodium berghei | PBANKA_0502700 | PHF5-like protein, putative |
Plasmodium falciparum | PF3D7_1018500 | PHF5-like protein, putative |
Plasmodium knowlesi | PKNH_0602800 | PHF5-like protein, putative |
Plasmodium vivax | PVX_001785 | hypothetical protein, conserved |
Saccharomyces cerevisiae | YPR094W | Rds3p |
Schistosoma japonicum | Sjp_0058950 | PHD finger-like domain-containing protein 5A, putative |
Schistosoma mansoni | Smp_011720 | hypothetical protein |
Schmidtea mediterranea | mk4.001325.02 | PHF-5 |
Trypanosoma brucei gambiense | Tbg972.10.9060 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.7390 | PHF5-like protein, putative |
Trypanosoma cruzi | TcCLB.507681.60 | PHF5-like protein, putative |
Toxoplasma gondii | TGME49_248250 | translation initiation factor IF-2, putative |
Theileria parva | TP02_0180 | hypothetical protein |
Trichomonas vaginalis | TVAG_447830 | pre-mRNA-splicing factor ini1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.7390 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.7390 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.7390 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.7390 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y54F10BM.14 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y54F10BM.14 | Caenorhabditis elegans | larval lethal | wormbase |
YPR094W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0502700 | Plasmodium berghei | Essential | plasmo |
TGME49_248250 | Toxoplasma gondii | Probably essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.